5 results
management diagnosis tuberculosis differential hivaids idsa infections ltbi mycobacterium myelitis neurology opportunistic prevention rheumatology sjogrens syndrome transverse
Tuberculosis Overview 10 million new M. tuberculosis infections/year Facultative intracellular rod-shaped bacteria Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... characteristic features Clinical ... Active TB: • ... Active TB: • ... #ActiveTB #LatentTB
Tuberculosis Overview 10 million new M. tuberculosis infections/year Facultative intracellular rod-shaped bacteria Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... characteristic features Clinical ... Active TB: • ... Active TB: • ... #ActiveTB #LatentTB
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS Treating LTBI (to prevent TB disease) Indications:
no evidence of active ... for active or latent ... authorities Treating Active ... HIV-infected persons with clinical ... infections #HIVAIDS #pharmacology
Transverse Myelitis Overview Focal inflammatory disorder of the spinal cord resulting in rapid onset of weakness, sensory
monophasic Pathophysiology ... Transverse Myelitis - Clinical ... • Infectious causes ... , Hep A/B/CMV, TB ... Transverse Myelitis Treatment
Sjogren's Syndrome Overview Epidemiology: • F > M: 9:1 • 5-6th Decades (can be any age) Autoimmune exocrinopathy multisystemic disease
Hypocomplementemia • Can cause ... salivary ducts Clinical ... phenomenon (16%) MSK ... Adenocarcinoma Treatment ... lubricants • Pharmacologic
No results found for "Exogenous activetb causes clinical pathophysiology pharmacology treatment msk tb latenttb"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Exogenous #activetb #causes #clinical #pathophysiology #pharmacology #treatment #msk #tb #latenttb